Related Experiment Video
Updated: Jun 5, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator
1Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.
Abstract:
Several ribosomal proteins regulate p53 function by modulating MDM2. We recently found that RPS27L, a RPS27-like protein, is a direct p53-inducible target. Here we showed that RPS27 itself is a p53-repressible target. Furthermore, the N-terminal region of either RPS27L or RPS27 binds to MDM2 on the central acidic domain of MDM2. RPS27L or RPS27 forms an in vivo triplex with MDM2-p53 and competes with p53 for MDM2 binding. Similar to p53, RPS27L, but not RPS27, is a short-lived protein and a novel MDM2 substrate. Degradation of RPS27L requires the RING or acidic domain of MDM2. Ectopic expression of RPS27L or RPS27 inhibits MDM-2-mediated p53 ubiquitination and increases p53 levels by extending p53 protein half-life, whereas siRNA silencing of RPS27L decreases p53 levels by shortening p53 half-life, with a corresponding reduction in p53 transcription activity. RPS27L is mainly localized in the cytoplasm, but upon p53-activating signals, a portion of RPS27L shuttled to the nucleoplasm where it colocalizes with MDM2. Both the cytoplasmic and the nuclear p53, induced by ribosomal stress, were reduced upon RPS27L silencing. Our study reveals a multilevel interplay between RPS27L/S27 and p53-MDM2 axis, with RPS27L functioning as a p53 target, a MDM2 substrate and a p53 regulator.
Insights
Ribosomal proteins RPS27L and RPS27 regulate the p53-MDM2 axis. RPS27L, a p53 target and MDM2 substrate, stabilizes p53 levels, impacting cell growth and stress responses.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Ribosomal proteins influence cellular processes, including tumor suppression.
- The p53-MDM2 axis is a critical regulator of cell fate, with MDM2 targeting p53 for degradation.
- RPS27L was previously identified as a p53-inducible gene, suggesting a role in the p53 pathway.
Purpose of the Study:
- To investigate the regulatory roles of RPS27L and RPS27 in the p53-MDM2 interaction.
- To elucidate the mechanisms by which RPS27L and RPS27 affect p53 stability and function.
- To determine the functional consequences of RPS27L and RPS27 interaction with MDM2.
Main Methods:
- Co-immunoprecipitation assays to assess protein-protein interactions.
- Western blotting to analyze protein levels and half-lives.
- siRNA-mediated gene silencing to evaluate functional impacts.
- Subcellular localization studies using immunofluorescence.
Main Results:
- RPS27L and RPS27 bind to MDM2, competing with p53 for binding and forming a triplex complex.
- RPS27L is a short-lived MDM2 substrate, and its degradation is dependent on MDM2 domains.
- Ectopic expression of RPS27L or RPS27 stabilizes p53 by inhibiting MDM2-mediated ubiquitination, while RPS27L silencing destabilizes p53.
- RPS27L shuttles to the nucleus upon p53 activation and is crucial for maintaining both cytoplasmic and nuclear p53 levels.
Conclusions:
- RPS27L and RPS27 are novel regulators of the p53-MDM2 axis.
- RPS27L acts as a p53 target, an MDM2 substrate, and a crucial regulator of p53 stability and function.
- The interplay between RPS27L/S27 and the p53-MDM2 pathway offers new insights into cancer biology and potential therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

